Yayınlar & Eserler

Yayın Ağı
Makaleler 6
Tümü (6)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (6)
ESCI (1)
Scopus (5)
TRDizin (1)

1. International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care

Holle L. M., Bilse T., Alabelewe R. M., Kintzel P. E., Kandemir E. A., Tan C. J., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.4, ss.785-801, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

2. Does therapeutic drug monitoring of hydroxychloroquine improve treatment outcome in intensive care unit patients with COVID-19?

Tecen-Yucel K., ARAS ATİK E., Bayraktar-Ekincioglu A.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.4, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

3. Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19?

ARAS E., Tecen-Yucel K., EKİNCİOĞLU A.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.7, ss.1807-1817, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. Capecitabine Induced Hand-Foot Syndrome: A Systematic Review of Case Reports

ARAS E., Tecen-Yucel K., Bayraktar-Ekincioglu A., Gullu I.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.9, sa.2, ss.178-191, 2019 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier

5. Evaluation of G-CSF (granulocyte colony stimulating factor) use in oncology outpatient clinic by the PRS (patient risk score) assessment

ARAS E., Tecen K., Bayraktar-Ekincioglu A., Demirkan K., KILIÇKAP S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.247, 2018 (SCI-Expanded, Scopus) identifier

6. Drug related problems in patients on oncology wards

ARAS E., Tecen K., Bayraktar-Ekincioglu A., Demirkan K.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.247, 2018 (SCI-Expanded, Scopus) identifier
Metrikler

Yayın

8

Yayın (WoS)

8

Yayın (Scopus)

7
BM Sürdürülebilir Kalkınma Amaçları